事業提携・ライセンシング・投資・M&A動向:January 2013(製薬業界)...市場調査レポートについてご紹介

【英文タイトル】Partnerships, Licensing, Investments and M&A Deals and Trends for January 2013 in Pharmaceuticals

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Pharmaceuticals & Healthcare, Global, Deal Summary, 7
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, January 2013 7
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, January 2013 9
2.2.1 MacroGenics Enters into Licensing Agreement with Gilead Sciences for DART Technology 9
2.2.2 Highmark to Acquire West Penn Allegheny Health System for $1.1 Billion 9
2.2.3 Allergan Commences Tender Offer to Acquire MAP Pharma, Migraine Drug Maker, for $958 Million 10
2.2.4 Tenet Healthcare Completed Private Placement of Notes Due 2021 for $850 Million 10
2.2.5 Baxter International to Acquire Rights to Hemophilia Compound OBI-1 and Related Assets for $700 Million 11
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, January 2013 12
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, January 2013 13
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 14
3.1 Pharmaceuticals & Healthcare, Global, M&A, January 2013 14
3.1.1 Top M&A Deals in January 2013 15
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, August 2012–January 2013 16
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, January 2013 17
3.2.1 Top Equity Offering Deals in January 2013 18
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, August 2012 – January 2013 19
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, January 2013 20
3.3.1 Top PE/VC Deals in January 2013 21
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, January 2013 22
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, January 2013 23
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, August 2012 – January 2013 25
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, August 2012 – January 2013 26
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, January 2013 27
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, January 2013 27
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, August 2012 – January 2013 28
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), January 2013 29
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, January 2013 30
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), August 2012 – January 2013 31
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number of Deals, August 2012 – January 2013 32
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), August 2012 – January 2013 33
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), August 2012 – January 2013 34
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, January 2013 35
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, January 2013 35
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), January 2013 36
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, January 2013 37
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, January 2013 37
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, January 2013 37
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), August 2012 – January 2013 38
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), August 2012 – January 2013 39
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), August 2012 – January 2013 40
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), August 2012 – January 2013 42
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 43
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, January 2013 43
6.1.1 Oncology – Deals of the Month 44
6.2 Pharmaceuticals & Healthcare, Global, Immunology Deals, January 2013 45
6.2.1 Immunology – Deal of the Month 46
6.3 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, January 2013 47
6.3.1 Central Nervous System – Deals of the Month 48
6.4 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, January 2013 49
6.4.1 Metabolic Disorders – Deal of the Month 50
6.5 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, January 2013 51
6.5.1 Infectious Diseases – Deals of the Month 52
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, January 2013 53
6.6.1 Cardiovascular – Deal of the Month 54
6.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals, January 2013 55
6.7.1 Gastrointestinal – Deals of the Month 56
7 Deal Summary by Geography 57
7.1 Pharmaceuticals & Healthcare, North America Deals, January 2013 57
7.1.1 North America – Deals of the Month 58
7.2 Pharmaceuticals & Healthcare, Europe, Deals, January 2013 60
7.2.1 Europe – Deals of the Month 61
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, January 2013 62
7.3.1 Asia-Pacific – Deals of the Month 63
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, January 2013 64
7.4.1 Rest of the World – Deals of the Month 65
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 66
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, August 2012 – January 2013 66
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, August 2012 – January 2013 67
9 Further Information 68
9.1 Methodology 68
9.2 About GlobalData 69
9.3 Contact Us 69
9.4 Disclosure information 69
9.5 Disclaimer 69


【レポート販売概要】

■ タイトル:事業提携・ライセンシング・投資・M&A動向:January 2013(製薬業界)
■ 英文:Partnerships, Licensing, Investments and M&A Deals and Trends for January 2013 in Pharmaceuticals
■ 発行日:2013年2月25日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160452
■ 調査対象地域:グローバル
  • ニューロモーフィックコンピューターの世界市場:用途別(信号処理、画像処理、データ処理、オブジェクト検出)、最終用途別、地域別、セグメント予測
    The global neuromorphic computing market size is expected to reach USD 6.48 billion by 2024, according to a new study by Grand View Research, Inc., registering a 20.2% CAGR during the forecast period. Rising demand for artificial intelligence and cognitive and brain robots is acting as a major growth driving factor for the market. Neuromorphic chips allow users to avail numerous advantages such as …
  • USBカーチャージャーの世界市場2019-2023
    About this market Consumer electronics and communication devices constitute a major end-use area for USB car chargers. The sale of smartphones and wearables and IoT devices will have a direct impact on the demand for USB car chargers during the forecast period. The speed of charging in smartphones as well as the availability of more than one charging sockets have been increasing with each incremen …
  • 急性冠症候群(Acute Coronary Syndrome)の治療薬開発:グローバル製薬企業動向
    PharmaPoint: Acute Coronary Syndrome - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Acute Coronary Syndrome - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing ACS Market. The report identifies and analyses the key companies shaping and driving the global …
  • アプリ広告の世界市場2015-2019
    About in-app advertising In-app advertising refers to advertisements incorporated into mobile applications and games. It is a relationship between app developers and ad networks, where the former has been paid by the latter for incorporating the network's code into the developer's app. In-app advertising is a recent trend that is being adopted by most brand managers, as it is an effective means of …
  • 性能添加剤の世界市場予測(~2021年):プラスチック添加剤、塗料添加剤、顔料添加剤、インク添加剤
    “Growing use in packaging and household goods industries is a prime factor for the growth of the performance additives market”The global performance additives market is projected to reach USD 110.35 billion by 2021, at a CAGR of 8.0%, in terms of value. This growth can be attributed in parts to the rising investments in new manufacturing plants for packaging in various countries. This growth also …
  • アルミニウムダイカスト機械の世界市場:HPDC、LPDC、その他
    Global Aluminum Die Casting Machinery Market: About this market Technavio’s aluminum die casting machinery market analysis considers sales from HPDC, LPDC, and others. Our analysis also considers the sales of aluminum die casting machinery in APAC, Europe, MEA, North America, and South America. In 2018, the HPDC segment had a significant market share, and this trend is expected to continue over th …
  • アンギオグラフィ(血管造影検査)装置の世界市場:製品別(アンギオグラフィシステム、カテーテル、ガイドワイヤー、バルーン、造影剤)、技術別(X線、CT、MRA)、処置別(冠動脈、血管内、神経血管)、用途別(診断、治療)、地域別予測
    Global Angiography equipment Market to reach USD 15.2 billion by 2025. Global Angiography equipment Market valued approximately USD 9.4 billion in 2016 is anticipated to grow with a healthy growth rate of more than 5.5% over the forecast period 2017-2025. Key factors which give growth of the market is attributed to the high prevalence of diseases such as cancer and CVDs, increasing product approva …
  • セルライト(Cellulite):世界の治験レビュー(2015年上半期版)
    Cellulite Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Cellulite Global Clinical Trials Review, H1, 2015" provides an overview of Cellulite clinical trials scenario. This report provides top line data relating to the clinical trials on Cellulite. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the g …
  • 世界のEVサービス装備市場動向(2012-2016)
    TechNavio's analysts forecast Global Electric Vehicle Service Equipment market to grow at a CAGR of 35.27 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing number of advanced vehicle technology projects. The Global Electric Vehicle Service Equipment market has also been witnessing the decrease in electric vehicle service equipment price. …
  • オーガニック乳製食品及び飲料の世界市場:有機牛乳、有機ヨーグルト、有機チーズ、その他の有機乳製品
    Organic dairy food and drinks are manufactured by using organic milk as a raw material collected from livestock with the help of organic farming methods. It mainly includes perishable products such as milk, yogurt, cheese, butter, and ice cream, which are used on a daily basis by consumers. Organic dairy products have 50% higher levels of beneficial omega-3 fatty acids than conventionally produced …
  • Rectal Cancer:グローバル臨床試験レビューH2, 2013
    Rectal Cancer Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Rectal Cancer Global Clinical Trials Review, H2, 2013" provides data on the Rectal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Rectal Cancer. It includes an overview of the trial numbers and their recruitment status as per the …
  • グローバルソイ製品市場におけるM&A動向(2014年3月)
    Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global soy products market during March 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global soy products market throughout the month. Additionally, the report provides an overview of all the …
  • サーモン缶詰の世界市場2016-2020
    About Salmon Salmon is the common name for fishes belonging to the family of Salmonidae. It is available from both wild and farmed sources. It is estimated that nearly 60% of the world's salmon production is farmed. Salmon farming started in the beginning of 1960s. Atlantic salmon is the most common type of salmon that is farmed. Major part of Atlantic salmon available around the globe are farmed …
  • Polyethylene Glycolの世界市場
    Polyethylene Glycols(PEG) (CAS 25322-68-3) Market Research Report 2013 presents comprehensive data on polyethylene glycols(peg) markets globally and regionally (Europe, Asia, North America etc.) The report includes polyethylene glycols(peg) description, covers its application areas and related patterns. It overviews polyethylene glycols(peg) market, names polyethylene glycols(peg) producers and in …
  • ジオフェンシングの世界市場2019-2023
    Technavio Announces the Publication of its Research Report – Global Geofencing Market 2019-2023 Technavio recognizes the following companies as the key players in the global geofencing market: Apple Inc., Esri, Localytics, Simpli.fi, Thumbvista. Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is the growing applications of geofencin …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。